Geniposide - A promising treatment for COVID-19 and atherosclerosis patients

Herbs And Phytochemicals: Researchers from the First Affiliated Hospital of Guangzhou University of Chinese Medicine in Guangzhou, China, have explored the therapeutic potential of the phytochemical geniposide in patients suffering from both COVID-19 and atherosclerosis (AS). This Herbs And Phytochemicals news report sheds light on the study, which utilized pharmacological and bioinformatics approaches to uncover the underlying mechanisms of geniposide. Geniposide is an iridoid glycoside derived from the dried, mature fruit of Gardenia jasminoides, commonly known as gardenia or cape jasmine. This compound has demonstrated anti-inflammatory and antioxidant properties, proving beneficial in various conditions such as cardiovascular disease, diabetes, nonalcoholic fatty liver disease, Alzheimer's disease, and Parkinson's disease. The findings indicate that this natural compound could offer significant benefits to patients with these comorbid conditions.


Geniposide - A promising treatment for COVID-19 and atherosclerosis patients

The Impact of Oxidative Stress
Oxidative stress (OS) has been identified as a critical factor in the severity of COVID-19 and the development of AS. Oxidative stress (OS) results from an imbalance between the production of reactive oxygen species (ROS) and the body's ability to counteract their harmful effects. This imbalance leads to cellular and tissue damage, which exacerbates disease conditions. Inflammation and oxidative damage are common in both COVID-19 and AS, leading to severe health complications. Geniposide, known for its anti-inflammatory and antioxidant properties, has shown promise in protecting cells against oxidative stress. However, the exact targets and mechanisms through which it operates in the context of COVID-19 and AS were previously unclear. This article discusses how the researchers aimed to bridge this knowledge gap.
 
Methodology
The study employed a combination of pharmacology and bioinformatics techniques to identify the targets of geniposide in patients with COVID-19 and AS. Researchers used databases such as the Gene Expression Omnibus (GEO) and other bioinformatics tools to extract relevant data. They identified 247 target genes modulated by geniposide in the context of COVID-19 and AS. These targets were analyzed to construct a protein-protein interaction (PPI) network, identifying 27 hub genes crucial for understanding the therapeutic potential of geniposide.
 
Key Findings
-Protein-Protein Interaction Network
The PPI network analysis revealed that geniposide interacts with several critical proteins involved in the pathology of COVID-19 and AS. Among the top targets were AKT1, CASP3, CAT, GAPDH, IL1B, IL6, INS, MAPK3, TNF, and TP53. These proteins play vital roles in inflammatory responses, oxidative stress, apoptosis, and immunity. The study highlighted the potential of geniposide to modulate these proteins, thereby offering therapeutic benefits.
 
-Enrichment Analysis
/>
Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed to understand the biological processes and pathways affected by geniposide. The results indicated that geniposide might regulate oxidative stress via the FoxO signaling pathway and other related pathways. This regulation is crucial for mitigating the inflammatory and oxidative damage seen in COVID-19 and AS patients.
 
-Detailed Analysis of Hub Genes
AKT1: A key player in cellular processes such as glucose metabolism, apoptosis, cell proliferation, transcription, and cell migration. It has been identified as a significant target in reducing tissue damage during COVID-19.
 
CASP3: A member of the cysteine-aspartic acid protease (caspase) family, CASP3 plays a critical role in the execution-phase of cell apoptosis. Its regulation is essential for controlling inflammation and apoptosis in COVID-19 and AS.
 
CAT: Catalase is an antioxidant enzyme that helps in the decomposition of hydrogen peroxide to water and oxygen, thus protecting cells from oxidative damage. Its role is crucial in reducing oxidative stress in both diseases.
 
GAPDH: Traditionally known for its role in glycolysis, GAPDH also participates in various cellular processes, including apoptosis, DNA repair, and oxidative stress. It is a significant player in the progression of AS and potentially in COVID-19.
 
IL1B and IL6: These interleukins are pro-inflammatory cytokines that play vital roles in the inflammatory response. They are involved in the pathogenesis of both COVID-19 and AS, making them crucial targets for geniposide.
 
INS: Insulin, encoded by the INS gene, is a vital hormone for glucose homeostasis. In the context of COVID-19, insulin regulation is essential, especially for patients with comorbid diabetes.
 
MAPK3: This gene encodes a protein involved in the MAP kinase signal transduction pathway, which affects various cellular processes, including proliferation, differentiation, and development.
 
TNF: Tumor necrosis factor is a cytokine involved in systemic inflammation. It is one of the cytokines that make up the acute phase reaction and is implicated in both COVID-19 and AS.
 
TP53: Also known as p53, this tumor suppressor protein plays a critical role in regulating the cell cycle and preventing cancer. It has been implicated in the response to COVID-19.
 
-Molecular Docking
Molecular docking studies were conducted to confirm the binding affinity of geniposide to the identified target proteins. The results showed that geniposide had a strong binding affinity for several key proteins, suggesting that it could effectively modulate their activity. The binding interactions included hydrogen bonds and other molecular interactions that stabilize the protein-ligand complexes.
 
-mRNA-miRNA Network
To explore the transcriptional regulation involved in the therapeutic effects of geniposide, researchers constructed an mRNA-miRNA regulatory network. The analysis identified hsa-miR-34a-5p as a critical miRNA involved in the regulation of the identified hub genes. This miRNA was found to play a significant role in endothelial and inflammatory signaling pathways, which are crucial in the context of COVID-19 and AS.
 
Conclusion
The study provides compelling evidence that geniposide could serve as a promising therapeutic agent for patients with COVID-19 and AS. By modulating key proteins and pathways involved in oxidative stress and inflammation, geniposide offers a multi-faceted approach to treating these conditions. The findings suggest that further research and clinical trials are warranted to fully explore the therapeutic potential of geniposide.
 
In conclusion, this study highlights the potential of geniposide as a therapeutic agent for managing COVID-19 and AS comorbidity. By targeting key proteins and pathways involved in oxidative stress and inflammation, geniposide may offer significant benefits in reducing disease severity and improving patient outcomes.
 
The study findings were published in the peer-reviewed journal: Medicine.
https://journals.lww.com/md-journal/fulltext/2024/08020/the_mechanism_of_geniposide_in_patients_with.8.aspx
 
For the latest on Herbs And Phytochemicals, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/covid-19-news-study-finds-that-the-phytochemical-sesamin-from-sesame-seeds-has-anti-covid-19-and-anti-inflammatory-properties
 
https://www.thailandmedical.news/news/herbs-and-phytochemicals-corilagin-from-hypophyllum-eliminates-macrophages-inflammation-in-atherosclerosis-through-tlr4-nf%CE%BAb-mapk-pathway